| Application no. and date | 18731853.0 (espacenet) (Federated) (European Patent Register), 20180621 | | Patent/reg. no. and date | DK/EP 3642340, 20240320 | | Publication date | 20200429 | | Priority no. and date | EP 17177237, 20170621, US 201762523061 P, 20170621, US 201715671086, 20170807 | | EP pub. no. and date |
EP 3642340 20200429 | | Effective date | | | Applicant/owner | Jazz Pharmaceuticals Ireland Limited, Fifth Floor, Waterloo Exchange,
Waterloo Road,
Dublin 4, IE | | Applicant ref. no. | V476897DK00 | | Inventor | Friedrich, Lars, Mettenstrasse 60
60638 Munich, DE,
O'DONNELL, Anne, 5 Ardagh Close
Blackrock
10 Dublin, IE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | C12N 9/82 (2006.01) | | Title | Modificeret L-asparaginase | | Int. application no. | EP2018066647 | | Int. publication no. | WO2018234492 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
